Evidence map›Paper›PMID 41411314›Full record

ArticlePloS one2025

Characterizing proximal risk for depressive symptoms and suicidal ideation with acute cannabis use and withdrawal among adolescents using ecological momentary assessment: Study protocol.

Isabella Feibus, Marta Borrego Mahiques, Meghan Costello, Kevin Potter, Kate H Bentley, Bettina B Hoeppner, Luwei Liu, Bryn Evohr, Lynn Yan, Jodi Gilman and 3 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06576076 (Characterizing Proximal Risk for Depressive Symptoms and Suicidal Ideation With Acute Cannabis Use and Withdrawal Among Adolescents Using Ecological Momentary Assessment), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06576076 narecruitingnot on this map

Characterizing Proximal Risk for Depressive Symptoms and Suicidal Ideation With Acute Cannabis Use and Withdrawal Among Adolescents Using Ecological Momentary Assessment

TypeinterventionalSponsorMassachusetts General HospitalRan2025 to 2029Enrolled200ConditionsCannabis Use, Depression, Suicidal Ideation, Adolescent BehaviorArmsContingency management for cannabis abstinence
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Isabella FeibusDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0009-0004-8354-0519
Marta Borrego MahiquesDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Meghan CostelloDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Kevin PotterDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Kate H BentleyDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Bettina B HoeppnerDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Luwei LiuDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Bryn EvohrDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Lynn YanDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Jodi GilmanDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts, United States of America.
A Eden EvinsDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Joe KossowskyDepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America.
Randi M SchusterDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-5710-9301

Funding

Characterizing Proximal Risk for Depressive Symptoms and Suicidal Ideation with Acute Cannabis Use and Withdrawal Among Adolescents Using Ecological Momentary AssessmentR01DA054145 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI Randi Melissa Schuster · 2024 to 2026
$2.3M
NIDA NIH HHS R01 DA054145
6 · The paper itself

Abstract

backgroundHeavy cannabis use often co-occurs with symptoms of depression in adolescents. Adolescents with past-year cannabis use are at increased risk of major depressive episodes and cannabis use is more than twice as common in adolescents with depression compared to those without. This study seeks to disentangle relationships between acute cannabis use, withdrawal, and abstinence on proximal depression and suicide risk using ecological momentary assessment (EMA) within the context of a randomized controlled trial comparing the effects of cannabis abstinence to cannabis use as usual.

methodsThis study will enroll 200 adolescents aged 12-18 who have daily or near-daily cannabis use and current depressive symptoms. Participants will complete 12 study visits over a 10-week period. At visit 2, participants will be randomized (1:1) to either 8 weeks of sustained cannabis abstinence encouraged through contingency management (CB-Abst) or a monitoring control group (CB-Mon). All participants will complete self-report and interview-based measures of substance use and symptom severity, along with 3 phases of EMA data collection (4 total weeks), involving 8 daily surveys that inquire about past-hour substance use, mood, and situational context. Phases will take place during baseline cannabis use, immediately after randomized abstinence, and following 8 weeks of sustained abstinence. The primary outcomes will be EMA-measured depressive symptoms and suicidal ideation across the 3 EMA phases, by randomized group. Exploratory outcomes will include Fitbit-derived measures of sleep, circadian rhythms, and step count. DISCUSSION: This is the first study, to our knowledge, to evaluate the acute effects of cannabis use, withdrawal, and sustained abstinence on mood among adolescents with heavy cannabis use and co-morbid symptoms of depression. Results will characterize periods of risk for fluctuations in mood and suicidal ideation across the withdrawal period and aim to guide intervention development to reduce depression and suicide risk among adolescents.

trial registrationClinicalTrials.gov NCT06576076.

Indexed as

DepressionEcological Momentary AssessmentMarijuana AbuseSubstance Withdrawal SyndromeSuicidal IdeationAdolescentCannabisChildFemaleHumansMaleRandomized Controlled Trials as TopicRisk Factors

Identifiers

PMID41411314
PMCPMC12714289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.